{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T19:52:20Z","timestamp":1793303540775,"version":"4.5.0"},"reference-count":72,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.bioorg.2025.108788","type":"journal-article","created":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T23:10:43Z","timestamp":1753398643000},"page":"108788","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":74,"special_numbering":"C","title":["N-substituted phthalimide\u2013carboxylic acid hybrids as dual-targeted aldose reductase inhibitors: Synthesis, mechanistic insights, and cancer-relevant profiling"],"prefix":"10.1016","volume":"163","author":[{"given":"Blinera","family":"Zognjani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arleta Rifati","family":"Nixha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hatice Esra","family":"Duran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa","family":"Arslan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gizem","family":"Y\u0131ld\u0131ztekin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3087-5145","authenticated-orcid":false,"given":"Abdulilah","family":"Ece","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00fcneyt","family":"T\u00fcrke\u015f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2025.108788_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113630","article-title":"Non-carboxylic acid inhibitors of aldose reductase based on N-substituted thiazolidinedione derivatives","volume":"223","author":"Mohd Siddique","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108788_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.117035","article-title":"Rational design and synthesis of novel N-benzylindole-based epalrestat analogs as selective aldose reductase inhibitors: an unexpected discovery of a new glucose-lowering agent (AK-4) acting as a mitochondrial uncoupler","volume":"281","author":"Kousaxidis","year":"2025","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108788_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114922","article-title":"Novel rhodanine based inhibitors of aldose reductase of non-acidic nature with p-hydroxybenzylidene functional group","volume":"246","author":"Kratky","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108788_bb0020","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.ejmech.2019.02.036","article-title":"Synthesis of new arylsulfonylspiroimidazolidine-2\u2032,4\u2032-diones and study of their effect on stimulation of insulin release from MIN6 cell line, inhibition of human aldose reductase, sorbitol accumulations in various tissues and oxidative stress","volume":"168","author":"Iqbal","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108788_bb0025","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.ejmech.2017.02.053","article-title":"Enhancing activity and selectivity in a series of pyrrol-1-yl-1-hydroxypyrazole-based aldose reductase inhibitors: the case of trifluoroacetylation","volume":"130","author":"Papastavrou","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108788_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115270","article-title":"Designed multiple ligands for the treatment of type 2 diabetes mellitus and its complications: discovery of (5-arylidene-4-oxo-2-thioxothiazolidin-3-yl)alkanoic acids active as novel dual-targeted PTP1B\/AKR1B1 inhibitors","volume":"252","author":"Maccari","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108788_bb0035","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.ejmech.2016.05.036","article-title":"A series of pyrido[2,3-b]pyrazin-3(4H)-one derivatives as aldose reductase inhibitors with antioxidant activity","volume":"121","author":"Han","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108788_bb0040","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.ejmech.2016.10.016","article-title":"Green fluorescent protein chromophore derivatives as a new class of aldose reductase inhibitors","volume":"125","author":"Saito","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108788_bb0045","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.ejmech.2016.08.070","article-title":"Design and synthesis of chiral 2H-chromene-N-imidazolo-amino acid conjugates as aldose reductase inhibitors","volume":"124","author":"Gopinath","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108788_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.104556","article-title":"QM\/MM analysis, synthesis and biological evaluation of epalrestat based mutual-prodrugs for diabetic neuropathy and nephropathy","volume":"108","author":"Choudhary","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2025.108788_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.106300","article-title":"Length and rigidity of the spacer impact on aldose reductase inhibition of the 5F-like ARIs in a dual-occupied mode","volume":"131","author":"Zeng","year":"2023","journal-title":"Bioorg. Chem."},{"issue":"2","key":"10.1016\/j.bioorg.2025.108788_bb0060","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1111\/jdi.12890","article-title":"Aldose reductase inhibitor ranirestat significantly improves nerve conduction velocity in diabetic polyneuropathy: a randomized double-blind placebo-controlled study in Japan","volume":"10","author":"Sekiguchi","year":"2019","journal-title":"J. Diabetes Invest."},{"key":"10.1016\/j.bioorg.2025.108788_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.104909","article-title":"Synthesis, molecular modeling, selective aldose reductase inhibition and hypoglycemic activity of novel meglitinides","volume":"111","author":"Salem","year":"2021","journal-title":"Bioorg. Chem."},{"issue":"11","key":"10.1016\/j.bioorg.2025.108788_bb0070","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1002\/cmdc.202100177","article-title":"Thiazolidinediones: an in\u2013depth study of their synthesis and application to medicinal chemistry in the treatment of diabetes mellitus","volume":"16","author":"Long","year":"2021","journal-title":"ChemMedChem"},{"issue":"10","key":"10.1016\/j.bioorg.2025.108788_bb0075","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1016\/S0968-0896(98)00139-4","article-title":"Molecular modeling studies of the binding modes of aldose reductase inhibitors at the active site of human aldose reductase","volume":"6","author":"Lee","year":"1998","journal-title":"Bioorg. Med. Chem."},{"issue":"15","key":"10.1016\/j.bioorg.2025.108788_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2020.115575","article-title":"Design synthesis and evaluation of novel aldose reductase inhibitors: the case of indolyl\u2013sulfonyl\u2013phenols","volume":"28","author":"Koutsopoulos","year":"2020","journal-title":"Bioorg. Med. Chem."},{"issue":"7","key":"10.1016\/j.bioorg.2025.108788_bb0085","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1007\/s12272-021-01343-5","article-title":"Aldose reductase: a cause and a potential target for the treatment of diabetic complications","volume":"44","author":"Thakur","year":"2021","journal-title":"Arch. Pharm. Res."},{"issue":"16","key":"10.1016\/j.bioorg.2025.108788_bb0090","doi-asserted-by":"crossref","first-page":"8890","DOI":"10.1111\/jcmm.15581","article-title":"Role of aldo-keto reductase family 1 member B1 (AKR1B1) in the cancer process and its therapeutic potential","volume":"24","author":"Khayami","year":"2020","journal-title":"J. Cell. Mol. Med."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108788_bb0095","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.pharmthera.2007.03.015","article-title":"Reactive carbonyls and oxidative stress: potential for therapeutic intervention","volume":"115","author":"Ellis","year":"2007","journal-title":"Pharmacol. Ther."},{"issue":"10","key":"10.1016\/j.bioorg.2025.108788_bb0100","doi-asserted-by":"crossref","first-page":"655","DOI":"10.3390\/metabo11100655","article-title":"Physiological and pathological roles of aldose reductase","volume":"11","author":"Singh","year":"2021","journal-title":"Metabolites"},{"issue":"2","key":"10.1016\/j.bioorg.2025.108788_bb0105","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/s41401-021-00788-0","article-title":"Ginsenoside Rb1 alleviates diabetic kidney podocyte injury by inhibiting aldose reductase activity","volume":"43","author":"He","year":"2022","journal-title":"Acta Pharmacol. Sin."},{"issue":"19","key":"10.1016\/j.bioorg.2025.108788_bb0110","doi-asserted-by":"crossref","first-page":"3683","DOI":"10.2174\/0929867327666201027152737","article-title":"Development of aldose reductase inhibitors for the treatment of inflammatory disorders and cancer: current drug design strategies and future directions","volume":"28","author":"Sonowal","year":"2021","journal-title":"Curr. Med. Chem."},{"issue":"17","key":"10.1016\/j.bioorg.2025.108788_bb0115","doi-asserted-by":"crossref","first-page":"6424","DOI":"10.1080\/07391102.2020.1800513","article-title":"Inhibitory effects of curcumin on aldose reductase and cyclooxygenase-2 enzymes","volume":"39","author":"Mirzaei","year":"2021","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.bioorg.2025.108788_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2024.117942","article-title":"Inhibition of LPS-induced inflammatory response in RAW264.7 cells by natural chlorogenic acid isomers involved with AKR1B1 inhibition","volume":"114","author":"Han","year":"2024","journal-title":"Bioorg. Med. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108788_bb0125","article-title":"Inhibition of aldose reductase by novel phytocompounds: a heuristic approach to treating diabetic retinopathy","volume":"2022","author":"Julius","year":"2022","journal-title":"Evid. Based Complement. Alternat. Med."},{"issue":"7","key":"10.1016\/j.bioorg.2025.108788_bb0130","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/s41571-021-00479-z","article-title":"Cancer therapies based on targeted protein degradation \u2014 lessons learned with lenalidomide","volume":"18","author":"Jan","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"9","key":"10.1016\/j.bioorg.2025.108788_bb0135","doi-asserted-by":"crossref","DOI":"10.1002\/slct.202204851","article-title":"Phthalimides represent a promising scaffold for multi-targeted anticancer agents","volume":"8","author":"Matore","year":"2023","journal-title":"ChemistrySelect"},{"issue":"1","key":"10.1016\/j.bioorg.2025.108788_bb0140","first-page":"125","article-title":"Phthalimides as anti-inflammatory agents, future","volume":"17","author":"Heras Martinez","year":"2025","journal-title":"Med. Chem."},{"issue":"7","key":"10.1016\/j.bioorg.2025.108788_bb0145","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1002\/ddr.22094","article-title":"Phthalimide as a versatile pharmacophore scaffold: unlocking its diverse biological activities","volume":"84","author":"Fernandes","year":"2023","journal-title":"Drug Dev. Res."},{"issue":"10","key":"10.1016\/j.bioorg.2025.108788_bb0150","doi-asserted-by":"crossref","first-page":"10385","DOI":"10.1021\/acsomega.4c10510","article-title":"Synthesis, pharmacological evaluation, and molecular Modeling of phthalimide derivatives as monoamine oxidase and cholinesterase dual inhibitors","volume":"10","author":"Abdullah","year":"2025","journal-title":"ACS Omega"},{"issue":"44","key":"10.1016\/j.bioorg.2025.108788_bb0155","doi-asserted-by":"crossref","first-page":"20519","DOI":"10.1039\/D1NJ03924E","article-title":"Beyond conventional construction of the phthalimide core: a review","volume":"45","author":"Das","year":"2021","journal-title":"New J. Chem."},{"issue":"7757","key":"10.1016\/j.bioorg.2025.108788_bb0160","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/s41586-019-1186-3","article-title":"Next-generation characterization of the cancer cell line encyclopedia","volume":"569","author":"Ghandi","year":"2019","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.bioorg.2025.108788_bb0165","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.cell.2017.06.010","article-title":"Defining a Cancer dependency map","volume":"170","author":"Tsherniak","year":"2017","journal-title":"Cell"},{"issue":"W1","key":"10.1016\/j.bioorg.2025.108788_bb0170","doi-asserted-by":"crossref","first-page":"W357","DOI":"10.1093\/nar\/gkz382","article-title":"SwissTargetPrediction: updated data and new features for efficient prediction of protein targets of small molecules","volume":"47","author":"Daina","year":"2019","journal-title":"Nucleic Acids Res."},{"issue":"4","key":"10.1016\/j.bioorg.2025.108788_bb0175","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1002\/qsar.200730051","article-title":"Benchmarking the reliability of QikProp. Correlation between experimental and predicted values","volume":"27","author":"Ioakimidis","year":"2008","journal-title":"QSAR Comb. Sci."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108788_bb0180","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(96)00423-1","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"23","author":"Lipinski","year":"1997","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108788_bb0185","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1021\/cc9800071","article-title":"A knowledge-based approach in designing combinatorial or medicinal chemistry libraries for drug discovery. 1. A qualitative and quantitative characterization of known drug databases","volume":"1","author":"Ghose","year":"1999","journal-title":"J. Comb. Chem."},{"issue":"12","key":"10.1016\/j.bioorg.2025.108788_bb0190","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1021\/jm020017n","article-title":"Molecular properties that influence the Oral bioavailability of drug candidates","volume":"45","author":"Veber","year":"2002","journal-title":"J. Med. Chem."},{"issue":"21","key":"10.1016\/j.bioorg.2025.108788_bb0195","doi-asserted-by":"crossref","first-page":"3867","DOI":"10.1021\/jm000292e","article-title":"Prediction of drug absorption using multivariate statistics","volume":"43","author":"Egan","year":"2000","journal-title":"J. Med. Chem."},{"issue":"12","key":"10.1016\/j.bioorg.2025.108788_bb0200","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1021\/jm015507e","article-title":"Simple selection criteria for drug-like chemical matter","volume":"44","author":"Muegge","year":"2001","journal-title":"J. Med. Chem."},{"issue":"7","key":"10.1016\/j.bioorg.2025.108788_bb0205","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1021\/jm901137j","article-title":"New substructure filters for removal of Pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays","volume":"53","author":"Baell","year":"2010","journal-title":"J. Med. Chem."},{"issue":"9","key":"10.1016\/j.bioorg.2025.108788_bb0210","doi-asserted-by":"crossref","first-page":"3164","DOI":"10.1021\/jm0492002","article-title":"A bioavailability score","volume":"48","author":"Martin","year":"2005","journal-title":"J. Med. Chem."},{"issue":"22","key":"10.1016\/j.bioorg.2025.108788_bb0215","doi-asserted-by":"crossref","first-page":"3681","DOI":"10.1016\/j.febslet.2013.09.031","article-title":"Inhibitor selectivity between aldo\u2013keto reductase superfamily members AKR1B10 and AKR1B1: role of Trp112 (Trp111)","volume":"587","author":"Zhang","year":"2013","journal-title":"FEBS Lett."},{"issue":"11","key":"10.1016\/j.bioorg.2025.108788_bb0220","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1021\/jm00161a033","article-title":"Antiinflammatory and aldose reductase inhibitory activity of some tricyclic arylacetic acids","volume":"29","author":"Cerelli","year":"1986","journal-title":"J. Med. Chem."},{"issue":"48","key":"10.1016\/j.bioorg.2025.108788_bb0225","doi-asserted-by":"crossref","DOI":"10.1002\/slct.202204050","article-title":"In vitro inhibitory activity and molecular docking study of selected natural phenolic compounds as AR and SDH inhibitors","volume":"7","author":"T\u00fcrke\u015f","year":"2022","journal-title":"ChemistrySelect"},{"issue":"12","key":"10.1016\/j.bioorg.2025.108788_bb0230","doi-asserted-by":"crossref","DOI":"10.1002\/jmr.2991","article-title":"N-substituted phthalazine sulfonamide derivatives as non-classical aldose reductase inhibitors","volume":"35","author":"T\u00fcrke\u015f","year":"2022","journal-title":"J. Mol. Recognit."},{"key":"10.1016\/j.bioorg.2025.108788_bb0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2025.108689","article-title":"Fluorenyl-phthalimide hybrids as potent aldose reductase inhibitors with selective anticancer activity: rational design, synthesis, and molecular insights","volume":"163","author":"Gundogdu","year":"2025","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2025.108788_bb0240","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.taap.2016.08.023","article-title":"A new brominated chalcone derivative suppresses the growth of gastric cancer cells in vitro and in vivo involving ROS mediated up-regulation of DR5 and 4 expression and apoptosis","volume":"309","author":"Zhang","year":"2016","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108788_bb0245","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1039\/D4MD00617H","article-title":"Novel benzenesulfonamides containing a dual triazole moiety with selective carbonic anhydrase inhibition and anticancer activity","volume":"16","author":"Buza","year":"2025","journal-title":"RSC Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108788_bb0250","series-title":"Schr\u00f6dinger Release 2025\u20131: QikProp, Schr\u00f6dinger, LLC, New York, NY","year":"2025"},{"issue":"1","key":"10.1016\/j.bioorg.2025.108788_bb0255","doi-asserted-by":"crossref","first-page":"42717","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioorg.2025.108788_bb0260","series-title":"Schr\u00f6dinger Release 2025\u20131: Protein Preparation Wizard, Schr\u00f6dinger, LLC, New York, NY","year":"2025"},{"key":"10.1016\/j.bioorg.2025.108788_bb0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.abb.2024.110161","article-title":"Aldose reductase with quinolone antibiotics interaction: in vitro and in silico approach of its relationship with diabetic complications","volume":"761","author":"T\u00fcrke\u015f","year":"2024","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.bioorg.2025.108788_bb0270","series-title":"Schr\u00f6dinger Release 2025\u20131: LigPrep, Schr\u00f6dinger, LLC, New York, NY","year":"2025"},{"issue":"40","key":"10.1016\/j.bioorg.2025.108788_bb0275","doi-asserted-by":"crossref","first-page":"11137","DOI":"10.1002\/slct.202103100","article-title":"Calcium Channel blockers: the effect of glutathione S-transferase enzyme activity and molecular docking studies","volume":"6","author":"T\u00fcrke\u015f","year":"2021","journal-title":"ChemistrySelect"},{"issue":"43","key":"10.1016\/j.bioorg.2025.108788_bb0280","doi-asserted-by":"crossref","first-page":"11915","DOI":"10.1002\/slct.202103197","article-title":"Infection medications: assessment in-vitro glutathione S-transferase inhibition and molecular docking study","volume":"6","author":"T\u00fcrke\u015f","year":"2021","journal-title":"ChemistrySelect"},{"key":"10.1016\/j.bioorg.2025.108788_bb0285","series-title":"Schr\u00f6dinger Release 2025\u20131: Epik, Schr\u00f6dinger, LLC, New York, NY","year":"2025"},{"issue":"33","key":"10.1016\/j.bioorg.2025.108788_bb0290","doi-asserted-by":"crossref","first-page":"9731","DOI":"10.1002\/slct.201902424","article-title":"In vitro and in silico studies on the toxic effects of antibacterial drugs as human serum Paraoxonase 1 inhibitor","volume":"4","author":"T\u00fcrke\u015f","year":"2019","journal-title":"ChemistrySelect"},{"key":"10.1016\/j.bioorg.2025.108788_bb0295","series-title":"Schr\u00f6dinger Release 2025\u20131: Receptor Grid Generation, Schr\u00f6dinger, LLC, New York, NY","year":"2025"},{"issue":"5","key":"10.1016\/j.bioorg.2025.108788_bb0300","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1080\/01480545.2019.1620266","article-title":"Gadolinium-based contrast agents: in vitro paraoxonase 1 inhibition, in silico studies","volume":"44","author":"Beydemir","year":"2021","journal-title":"Drug Chem. Toxicol."},{"key":"10.1016\/j.bioorg.2025.108788_bb0305","series-title":"Schr\u00f6dinger Release 2025\u20131: Glide, Schr\u00f6dinger, LLC, New York, NY","year":"2025"},{"issue":"7","key":"10.1016\/j.bioorg.2025.108788_bb0310","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1021\/jm0306430","article-title":"Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy","volume":"47","author":"Friesner","year":"2004","journal-title":"J. Med. Chem."},{"issue":"7","key":"10.1016\/j.bioorg.2025.108788_bb0315","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1021\/jm030644s","article-title":"Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening","volume":"47","author":"Halgren","year":"2004","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108788_bb0320","series-title":"Schr\u00f6dinger Release 2025\u20131: Prime, Schr\u00f6dinger, LLC, New York, NY","year":"2025"},{"issue":"6","key":"10.1016\/j.bioorg.2025.108788_bb0325","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1021\/ci700271z","article-title":"Search for non-nucleoside inhibitors of HIV-1 reverse transcriptase using chemical similarity, molecular docking, and MM-GB\/SA scoring","volume":"47","author":"Barreiro","year":"2007","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.bioorg.2025.108788_bb0330","series-title":"Schr\u00f6dinger Release 2025\u20131: Maestro, Schr\u00f6dinger, LLC, New York, NY","year":"2025"},{"key":"10.1016\/j.bioorg.2025.108788_bb0335","doi-asserted-by":"crossref","DOI":"10.1016\/j.molliq.2024.125558","article-title":"Bioactivity, cytotoxicity, and molecular modeling studies of novel sulfonamides as dual inhibitors of carbonic anhydrases and acetylcholinesterase","volume":"410","author":"G\u00fcle\u00e7","year":"2024","journal-title":"J. Mol. Liq."},{"key":"10.1016\/j.bioorg.2025.108788_bb0340","series-title":"Schr\u00f6dinger Release 2025\u20131: Desmond, Schr\u00f6dinger, LLC, New York, NY","year":"2025"},{"issue":"1","key":"10.1016\/j.bioorg.2025.108788_bb0345","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s13065-023-00939-w","article-title":"Computer-aided drug design","volume":"17","author":"Ece","year":"2023","journal-title":"BMC Chem."},{"key":"10.1016\/j.bioorg.2025.108788_bb0350","series-title":"Computer-Aided Drug Discovery","first-page":"1","article-title":"Molecular dynamics simulations and computer-aided drug discovery","author":"Godwin","year":"2016"},{"key":"10.1016\/j.bioorg.2025.108788_bb0355","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2023.110655","article-title":"Novel coumarin-chalcone derivatives: synthesis, characterization, antioxidant, cyclic voltammetry, molecular modelling and biological evaluation studies as acetylcholinesterase, \u03b1-glycosidase, and carbonic anhydrase inhibitors","volume":"383","author":"\u00c7elik Onar","year":"2023","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.bioorg.2025.108788_bb0360","series-title":"Schr\u00f6dinger Release 2025\u20131: Jaguar, Schr\u00f6dinger, LLC, New York, NY","year":"2025"}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825006686?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825006686?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T05:03:00Z","timestamp":1776920580000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206825006686"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":72,"alternative-id":["S0045206825006686"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.108788","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"N-substituted phthalimide\u2013carboxylic acid hybrids as dual-targeted aldose reductase inhibitors: Synthesis, mechanistic insights, and cancer-relevant profiling","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.108788","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108788"}}